Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 16 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 11149082

    Multispecific antibodies targeting human immunodeficiency virus and methods of using the same

    The United States of America, As Represented By · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  2. US 11147867

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  3. US 11136356

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  4. US 11136372

    ApoC-II mimetic peptides

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  5. US 11129835

    Methods and compositions for the inhibition of PIN1

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  6. US 11130785

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  7. US 11116830

    Bacterial polysaccharide-conjugated carrier proteins and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  8. US 11110150

    Complexes of IL-15 and IL-15Ralpha and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  9. US 11110089

    Pyridazinones and their use in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  10. US 11111478

    Methods of producing T memory stem cell populations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  11. US 11110181

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  12. US 11111306

    IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  13. US 11103572

    Thermal inactivation of rotavirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

  14. US 11096927

    Anti-flavivirus compounds and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  15. US 11098053

    Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  16. US 11098054

    Englerin derivatives for treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Sciences · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  17. US 11098084

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  18. US 11098283

    T cells modified to overexpress c-Myb

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  19. US 11091509

    HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  20. US 11083775

    Transgenic corn with antifungal peptide AGM182 USDA (DN:0113.18)

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  21. US 11084850

    Recombinant prefusion RSV F proteins and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  22. US 11084856

    Interleukin-4 receptor-binding fusion proteins and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  23. US 11077182

    Methods of preparing anti-human papillomavirus antigen T cells

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  24. US 11077178

    Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.